Approval · Notice of Compliance 4102 · 1997
CLOPIXOL: Notice of Compliance 4102
Issued January 30, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4102
- Date
- January 30, 1997
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antipsychotic
Products in this notice
Medicinal ingredients
- ZUCLOPENTHIXOL HYDROCHLORIDE 10 MG per TAB
- ZUCLOPENTHIXOL HYDROCHLORIDE 25 MG per TAB
- ZUCLOPENTHIXOL HYDROCHLORIDE 40 MG per TAB
- ZUCLOPENTHIXOL ACETATE 50 MG per ML
- ZUCLOPENTHIXOL DECANOATE 200 MG per ML
- ZUCLOPENTHIXOL DECANOATE 500 MG per ML